Author page: Femtech Insider

Helpful App Raises $7.5M in Seed Funding to Streamline Caregiver Support

Helpful, an app aimed at assisting over 53 million American caregivers, has secured a $7.5M in seed funding made possible through Redesign Health. The app addresses the mounting challenges caregivers face by simplifying the administrative aspects of caregiving, bringing together insurance benefits, medical records, and resources in a user-friendly platform. This funding will help the company to broaden its services and extend…

Peterson Center on Healthcare Launches $50M Initiative to Evaluate Digital Health Innovations

The Peterson Center on Healthcare has introduced the Peterson Health Technology Institute (PHTI), a non-profit venture aimed at assessing emerging healthcare technologies. With an initial $50M commitment, PHTI will conduct evidence-based evaluations of digital health solutions’ clinical benefits, economic impact, and considerations like equity, privacy, and security. Digital health technologies hold the potential to revolutionize healthcare delivery, improve patient experiences, and lower…

BPEA EQT to Acquire a Majority Stake in Indira IVF, India’s Largest Chain of Fertility Clinics

BPEA Private Equity Fund VIII, known as BPEA EQT, is in the process of acquiring a majority stake in Indira IVF, India’s foremost fertility services provider valuing the firm at $1.1 billion according to Reuters. With a network of 116 centers spanning 20 states, Indira IVF conducts about 40,000 IVF cycles annually, resulting in over 125,000 successful pregnancies. The move aligns with…

FDA Approves First Oral Treatment for Postpartum Depression

The U.S. Food and Drug Administration (FDA) has approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs after childbirth but can also begin during the later stages of pregnancy. Until now, treatment for PPD was only available as an IV injection given by a healthcare provider in certain healthcare…

Flo Health Survey Reveals Knowledge Gaps and Lack of Access to Credible Health Information in Post-Roe America

In the aftermath of the landmark overturning of Roe v. Wade, American women find themselves navigating a complex landscape, where access to credible women’s health information has become increasingly scarce. Assessing this troubling scenario, Flo Health has released a new report titled “Failed foundations: The women’s health crisis in post-Roe America.” The report exposes glaring knowledge gaps across sexual and menstrual health,…

“There’s an App for it”: New Research Assesses Mobile Apps Providing Abortion Information

In a world where “there’s an app for that” is more than just a slogan, navigating the plethora of health-related applications can be daunting for consumers. This is particularly true when it comes to finding accurate and reliable information about abortion. A group of researchers set out to analyze the mobile app landscape in this critical area of women’s health. Their recently…

Mirvie Receives a $4.6M Grant from the Gates Foundation to Study Preeclampsia in Sub-Saharan Africa

Mirvie, a prenatal diagnostics company has received a $4.6M grant from the Bill & Melinda Gates Foundation to support the company’s efforts to predict unexpected pregnancy complications before they happen by revealing the underlying biology of each pregnancy for women on a global scale. Specifically, the funding will help launch study sites in Cameroon, Ghana, and Zambia to understand preeclampsia among pregnant…

What’s New in Femtech This Week? (Aug 3, 2023)

Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights HerMD adds $18M to expand its women’s health clinic network. Béa Fertility secures £2.5M to launch its at-home fertility treatment in the UK. Pelvital raises $2.68M for Flyte, its FDA-cleared treatment…